Full Text View
Tabular View
No Study Results Posted
Related Studies
Study of OSI-211 vs. Topotecan in Patients With Relapsed Epithelial Ovarian Cancer
This study has been completed.
Study NCT00046800   Information provided by Astellas Pharma Inc
First Received: October 3, 2002   Last Updated: October 18, 2011   History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study
About Study Results Reporting on ClinicalTrials.gov
  Study Status: This study has been completed.
  Study Completion Date: March 2003
  Estimated Primary Completion Date: No date given